1The EUCLID Study Group. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria.Lancet 1997;349(9068):1787-92.
2Kasiske BL, Kalil RS, Ma JL, et al. Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med 1993;118(2):129-38.
3Kvemy J, Gregrersen G, Pedersen RS. Randomized place-bocontrolled trial of perindopril in normoternsive, normoalbuminuric patients with type 2 diabetes mellitus. QJM 2001;94(2):89-94.
4The European Study for the Prevention of Renal Disease in Type 1 Diabetes(ESPRIT). Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria. Diabetes 2001 ; 50 (4) : 843 - 50.
5Nankervis A, Nicholls K, Kilmartin G. Effects of perindopril on renal histomorphometry in diabetic subjects with microalbuminuria: a 3-year placebo-controlled biopsy study. Metabolism 1998 ; 37( 12 Suppl 1 ) : 12- 5.
6Ahmed A, Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency:how concerned hould we be by the rise in serum creatiniine? J Am Geriatr Soc 2002;50(7):1297-300.
7Heart Outcomes Prevention Evaluaation Study Investigators. Effects of ramipril on cardiovascular and microvaseular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Laneet 2000;355(9200):253-9.
8Hod M, van Dijk DJ, Karp M, et al. Diabetic nephropathy and pregnancy: the effect of ACE inhibitors prior to pregnancy on fetomatemal outcome. Nephrol Dial transplant 1995 ; 10 ( 12 ) :2328- 33.
9Shigihara T, Sato A, Hayashi K, et al. Effect of combination therapy of angiotensin-converting enzyme inhibitor plus calcium channel blocker on urinary albumin excretion in hypertensive microalbuminuric patients with type Ⅱ diabetes. H Ypertens Res 2000;23(3) :219-26.
10Josefsberg Z, Ross SA, Lev Ran A, et al. Effects of enalapril and nitrendipine on the excretion of epidermal growth factor and albumin in hypertensive NIDDM patients. Diabetes Care 1995;18(5):690-3.
4Asplund K. Antioxidant vitamins in the prevention of cardiov - ascular disease: a systematic review[J ]. Intern Med,2002,251:372- 392.
5Lonn E, Yusufs, Hoogwerf B, et al. Effects of vitamin E on cardiovascular and microvascular outcomes in high- risk patients with diabetes: results of the HOPE study and MICRO- HOPE sub - study[J]. Diabetes Care, 2002,25 ( 11 ) : 1919 - 1920.
